Synthesis and in-vitro antimycobacterial studies of cysteine capped silver nano-particles

Synthesis and Reactivity in Inorganic, Metal-Organic and Nano-Metal Chemistry

Volumn 39, Issue 9, 2009, Pages 554-558

  Varghese, Mithun V ^a,b   Dhumal, Ravindra S ^b   Patil, Sharvil S ^a,b   Paradkar, Anant R ^b   Khanna, Pawan K ^a  

^a CENTRE FOR MATERIALS FOR ELECTRONICS TECHNOLOGY C MET   (India)

^b BHARATI VIDYAPEETH DEEMED UNIVERSITY   (India)

Author keywords

Cysteine; Mycobacterium tuberculae; Nanobioconjugate; Silver nano particle

Indexed keywords

EID: 71049116756     PISSN: 15533174     EISSN: 15533182     Source Type: Journal    
DOI: 10.1080/15533170903327869     Document Type: Article

References (25)

1. Maartens, G., and Wilkinson, R.J. Tuberculosis. Lancet, 2007, 370(9604), 2030-2043.
2. Snider, D.E.J., Raviglione,M., and Kochi, A. global burden of tuberculosis. Tuberculosis, 1994, 3-11.
3. World Health Organization. WHO declares tuberculosis a global emergency. Soz-Praevmed., 1993, 38, 251-252.
4. Deol, P., Khuller, G.K., and Joshi, K. Therapeutic efficacies of isoniazid and rifampin encapsulated in lung-specific stealth liposomes against Mycobacterium tuberculosis infection induced in mice. Antimicrob Agents Ch., 1997, 41, 1211-1214.
5. Barrow, E.L., Winchester, G.A., Staas, J.K., Quenelle, D.C., and Barrow, W.W. Use of microsphere technology for targeted delivery of rifampin to Mycobacterium tuberculosis infected macrophages. Antimicrob Agents Ch., 1998, 42, 2682-2689.
6. Sharma, R., Saxena, D., Dwivedim A.K., and Misra, A. Inhalable microparticles containing drug combinations to target alveolar macrophages for treatment of pulmonary tuberculosis. Pharmaceut Res., 2001, 18, 1405-1410.
7. Esmaeili, F., Hosseini-Nasr,M., Rad-Malekshahi, M., Samadi, N., Atyabim F., and Dinarvand, R. Preparation and antibacterial activity evaluation of rifampicin-loaded poly lactide-co-glycolide nanoparticles. Nanomedicine, 2007, 3, 161-167.
8. Prabakaran, D., Singh, P., Jaganathan, K.S., and Vyas, S.P. Osmotically regulated asymmetric capsular systems for simultaneous sustained delivery of anti-tubercular drugs. J Control Release, 2004, 95, 239-248.
9. Salata, O.V. Applications of nanoparticles in biology andmedicine. Journal of Nanobiotechnology, 2004, 2(3), 1-6.
10. Shrivastava, S., Bera, T., Roy, A., Singh, G., Ramachandrarao, P., and Dash, D. Characterization of enhanced antibacterial effects of novel silver nanoparticles. Nanotechnology, 2007, 18, 1-9.
11. Bhumkar, D.R., Joshi, H.M., Sastry, M., and Pokharkar, V.B. Chitosan reduced gold nanoparticles as novel carriers for transmucosal delivery of insulin. Pharmaceut Res., 2007, 24, 1115-1126.
12. Dhumal, R.S., Biradar, S.V., Yamamura, S., Paradkar, A.R., and York, P. Preparation of amorphous cefuroxime axetil nanoparticles by sonoprecipitation for enhancement of bioavailability. Eur. J. Pharm. Biopharm., 2008, 70, 109-115.
13. Pal, S., Tak,Y., and Song, J. Does the antibacterial activity of silver nanoparticles depend on the hape of sthe nanoparticle? a study of the gram-negative bacterium Escherichia coli. Appl. Environ. Microbiol 2007, 73, 1712-1720
14. Dibrov, P., Dzioba, J., Gosink, K., and Hase, C. Chemiosmotic mechanism of antimicrobial activity of ag+ in vibrio cholera. J Antimicrob Chemoth, 2002, 46, 2668-2670
15. Shahverdi, A., Fakhimi, A., Shahverdi, H., Minaian, S. Synthesis and effect of silver nanoparticles on the antibacterial activity of different antibioticsagainst Staphylococcus aureus and Escherichia colli. Nanomedicine, 2007, 3, 168-171.
16. Lin, Y.-S.E., Vidic, R.D., Stout, J.E., Mccartney, C.A., and Yu, V.L. Inactivation of Mycobacterium avium by copper and silver ions. Water Res., 1998, 32, 1997-2000.
17. Li, P., Li, J., Wu, C., Wu, Q., and Li, J. Synergistic antibacterial effects of β-lactam antibiotic combined with silver nanoparticles. Nanotechnology, 2005, 16, 1912-1917.
18. Khanna, P.K., Gokhale, R., and Subbarao, V. Poly (vinyl pyrolidone) coated silver nano powder via displacement reaction. J. Mat. Sci., 2004, 39, 3773-3776.
19. Bhattacharya, R., Patra, C., Earl, A., Wang, S., Katarya, A., and Lu, L. Attaching folic acid on gold nanoparticles using noncovalent interaction via different polyethylene glycol backbones and targeting of cancer cells. Nanomedicine, 2007, 3, 224-238.
20. Hede, S., and Apte, K. Cardiovascular effects of cetyl trimethyl ammonium bromide protected gold nanoparticles. Indian J Pharmacol., 2007, 39, 210-213.
21. Elechiguerra, J.L., Burt, J.L., Morones, J.R., Camacho-Bragado, A., Gao, X., and Lara, H. Interaction of silver nanoparticles with HIV-1. J Nanobiotechnology, 2005, 3(6), 1-10.
22. Qing Shan, W., Jian, J., Jin Hong, F., and Jia Cong, S. Norvancomycincapped silver nanoparticles: Synthesis and antibacterial activities against E. coli. Sci China Ser B: Chemistry, 2007, 50(3), 418-424.
23. Aryal, S., Remant, B.K.C., Dharmaraj, N., Bhattarai, N., Kim, C.H., and Kim, H.Y. Spectroscopic identification of S-Au interaction in cysteine capped gold nanoparticles. Spectrochim Acta A, 2006, 63, 160-163.
24. Patil, S.S., Dhumal, R.S., Varghese, M.V., Paradkar, A.R., and Khanna, P,K. Synthesis and Antibacterial Studies of Chloramphenicol LoadedNanosilver against Salmonella typhi. J. Synth. React. Inorg., Metal-Org. Nano- Metal Chem., (in press) 2008.
25. Indira,M., and Sirsi,M.Nutritional studies on mycobacterium tuberculosiseffect of amino acids on the 'in-vitro' growth of mycobacterium tuberculosis. Ind. J. Tub., 1960, 4, 75-82.